ALL KEYWORDS
Bladder Cancer Genomics
Related Specialists
Showing 3 of 31
Related Fact Sheets
Related Clinical Trials
Showing 2 of 4
A Phase 2, Randomized, Multi-center, Open Label Trial to Evaluate the Safety and Efficacy of Intravesical Nadofaragene Firadenovec Alone or in Combination with Chemotherapy or Immunotherapy in Participants with High-grade Bacillus Calmette-Guerin Therapy (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
- Bladder Cancer
MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer
- Bladder Cancer
Related Departments
Showing 3 of 17